These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8023874)

  • 21. [Clinical features of patients with Behcet's uveitis].
    Liu XS; Gao F; Zhao C; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2020 Mar; 56(3):217-223. PubMed ID: 32187951
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term follow-up of patients with chronic uveitis affecting the posterior pole treated with combination cyclosporine and ketoconazole.
    Ramadan AM; Nussenblatt RB; de Smet MD
    Ophthalmology; 1997 Apr; 104(4):706-11. PubMed ID: 9111267
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine for Behçet's uveitis: is it associated with an increased risk of neurological involvement?
    Akman-Demir G; Ayranci O; Kurtuncu M; Vanli EN; Mutlu M; Tugal-Tutkun I
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S84-90. PubMed ID: 19026121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ocular Manifestations in Late Onset Behçet's Disease.
    Saadouli D; Mansour KB; Yahyaoui S; Afrit NE; Lahmar A; Afrit AE
    Curr Aging Sci; 2021; 14(1):56-61. PubMed ID: 31994475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Efficacy and Safety of Interferon Alpha-2a in the Treatment of Chinese Patients with Behçet's Uveitis Not Responding to Conventional Therapy.
    Yang P; Huang G; Du L; Ye Z; Hu K; Wang C; Qi J; Liang L; Wu L; Cao Q; Kijlstra A
    Ocul Immunol Inflamm; 2019; 27(1):7-14. PubMed ID: 29040035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet's disease-related uveitis: a multicenter retrospective observational study.
    Fabiani C; Vitale A; Emmi G; Lopalco G; Vannozzi L; Guerriero S; Gentileschi S; Bacherini D; Franceschini R; Frediani B; Galeazzi M; Iannone F; Tosi GM; Cantarini L
    Clin Rheumatol; 2017 Jan; 36(1):191-197. PubMed ID: 27981463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early administration of adalimumab for paediatric uveitis due to Behçet's disease.
    Hiyama T; Harada Y; Doi T; Kiuchi Y
    Pediatr Rheumatol Online J; 2019 Jun; 17(1):29. PubMed ID: 31182107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern and causes of visual loss in Behçet's uveitis: short-term and long-term outcomes.
    Amer R; Alsughayyar W; Almeida D
    Graefes Arch Clin Exp Ophthalmol; 2017 Jul; 255(7):1423-1432. PubMed ID: 28396946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose cyclosporin-A therapy in Behçet's disease.
    Sajjadi H; Soheilian M; Ahmadieh H; Hassanein K; Parvin M; Azarmina M; Ehyaee V; Amiransari B
    J Ocul Pharmacol; 1994; 10(3):553-60. PubMed ID: 7836864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful Treatment with Infliximab for Refractory Uveitis in a Hemodialysis Patient with Behçet's Disease and a Review of the Literature for Infliximab Use in Patients on Hemodialysis.
    Kurata I; Tsuboi H; Takahashi H; Abe S; Ebe H; Hagiwara S; Umeda N; Kondo Y; Ogishima H; Suzuki T; Matsumoto I; Hoshi S; Oshika T; Sumida T
    Intern Med; 2015; 54(12):1553-7. PubMed ID: 26073249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial.
    Ozyazgan Y; Yurdakul S; Yazici H; Tüzün B; Işçimen A; Tüzün Y; Aktunç T; Pazarli H; Hamuryudan V; Müftüoğlu A
    Br J Ophthalmol; 1992 Apr; 76(4):241-3. PubMed ID: 1390495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Behçet's disease: a multicenter study.
    Takeuchi M; Kezuka T; Sugita S; Keino H; Namba K; Kaburaki T; Maruyama K; Nakai K; Hijioka K; Shibuya E; Komae K; Hori J; Ohguro N; Sonoda KH; Mizuki N; Okada AA; Ishibashi T; Goto H; Mochizuki M
    Ophthalmology; 2014 Oct; 121(10):1877-84. PubMed ID: 24950593
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclosporine therapy for uveitis: long-term followup.
    Nussenblatt RB; Palestine AG; Chan CC
    J Ocul Pharmacol; 1985; 1(4):369-82. PubMed ID: 3880086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term chlorambucil for refractory uveitis in Behcet's disease.
    Mudun BA; Ergen A; Ipcioglu SU; Burumcek EY; Durlu Y; Arslan MO
    Ocul Immunol Inflamm; 2001 Dec; 9(4):219-29. PubMed ID: 11935432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of interferon alpha-2a therapy in patients with Behcet's disease.
    Yalçindağ FN; Uzun A
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):439-43. PubMed ID: 22455657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ocular involvement in Behçet's disease.
    Peplinski LS
    J Am Optom Assoc; 1989 Nov; 60(11):854-7. PubMed ID: 2607080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose cyclosporin A therapy in treating chronic, noninfectious uveitis.
    Vitale AT; Rodriguez A; Foster CS
    Ophthalmology; 1996 Mar; 103(3):365-73; discussion 373-4. PubMed ID: 8600411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease.
    Gueudry J; Wechsler B; Terrada C; Gendron G; Cassoux N; Fardeau C; Lehoang P; Piette JC; Bodaghi B
    Am J Ophthalmol; 2008 Dec; 146(6):837-44.e1. PubMed ID: 19027420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical and clinical study of FK506 in uveitis.
    Mochizuki M; Ikeda E; Shirao M; Fujito S; Yoshimura K; Shimada N
    Curr Eye Res; 1992; 11 Suppl():87-95. PubMed ID: 1385045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of cyclosporin-a in the treatment of Behçet's disease.
    Atmaca LS; Batioğlu F
    Ophthalmic Surg; 1994 May; 25(5):321-7. PubMed ID: 8058265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.